Page last updated: 2024-09-03
efaproxiral and Animal Mammary Carcinoma
efaproxiral has been researched along with Animal Mammary Carcinoma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Donnelly, ET; Liu, Y; Rockwell, S | 1 |
Other Studies
1 other study(ies) available for efaproxiral and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Efaproxiral (RSR13) plus oxygen breathing increases the therapeutic ratio of carboplatin in EMT6 mouse mammary tumors.
Topics: Alkylating Agents; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Oxygen; Propionates; Respiration; Time Factors | 2006 |